Molecular basis of complement C3 deficiency in guinea pigs

Area of Science:

• Biochemistry
• Immunology
• Genetics

Background:

• Genetically determined deficiencies in complement component 3 (C3) can impair immune function.
• Understanding the molecular basis of C3 deficiency is crucial for diagnosing and potentially treating complement-related disorders.

Purpose of the Study:

• To investigate the biochemical basis of a genetically determined C3 deficiency in guinea pigs.
• To determine if the deficiency results from issues with C3 gene expression, protein synthesis, or post-translational modification.

Main Methods:

• Analysis of C3 messenger RNA (mRNA) size and quantity in C3-deficient macrophages.
• In vitro synthesis and secretion studies using oocytes and macrophage cultures.
• Assessment of C3 protein cleavage, susceptibility to proteolysis, and methylamine incorporation.
• Direct sequence analysis of C3 cDNA from deficient and sufficient guinea pig liver libraries.
• Identification of restriction fragment length polymorphisms (RFLPs) in the C3 gene.

Main Results:

• C3-deficient guinea pigs possess normal-sized C3 mRNA in normal amounts.
• Synthesized pro-C3 protein is secreted normally but fails autolytic cleavage and is prone to proteolysis.
• C3 protein from deficient animals shows impaired methylamine incorporation, suggesting a defect in the thiolester bridge.
• Sequence analysis ruled out mutations in the primary structure of C3.
• Identified C3 gene RFLPs independent of the deficiency phenotype.

Conclusions:

• The C3 deficiency in guinea pigs stems from a post-translational processing defect, not a mutation in the C3 gene or its mRNA.
• The identified RFLPs serve as a valuable genetic marker for studying the inheritance and mechanisms of this C3 deficiency.